Radiosensitization by gold nanoparticles: effective at megavoltage energies and potential role of oxidative stress

The multidisciplinary field of nanotechnology has the potential to deliver many novel applications in the biomedical field including improved strategies for the detection, diagnosis and treatment of cancer. In the radiation research arena, gold nanoparticles (GNPs) have demonstrated strong potential as diagnostic imaging agents, drug delivery platforms and radiation sensitizers due to their attractive physico-chemical characteristics. In the pursuit of dose modifiers to improve the therapeutic index of radiotherapy, GNPs have attracted much research interest due to the high atomic number (Z) of gold which results in significantly improved contrast compared to soft tissue. In this review, we consider the physical properties of GNPs which make them widely utilizable in the field of radiation research as image contrast agents, drug delivery vehicles and radiation sensitizers. In particular, we focus on the growing amount of preclinical evidence which demonstrates GNPs as radiation sensitizers and highlight the disparity between observed experimental findings and predictions based on mass attenuation, GNP concentration and beam energy. Considering the large amount of studies performed using a wide range of GNPs, emerging evidence suggests oxidative stress as a central mechanism of radiobiological response.

[1]  Salomeh Jelveh,et al.  Gold Nanoparticles as Radiation Sensitizers in Cancer Therapy , 2010, Radiation research.

[2]  A. Shiau,et al.  Increased apoptotic potential and dose‐enhancing effect of gold nanoparticles in combination with single‐dose clinical electron beams on tumor‐bearing mice , 2008, Cancer science.

[3]  Jie Chen,et al.  Enhancement of radiation cytotoxicity in breast-cancer cells by localized attachment of gold nanoparticles. , 2008, Small.

[4]  D. Harder,et al.  Enhanced Values of the RBE and H Ratio for Cytogenetic Effects Induced by Secondary Electrons from an X-Irradiated Gold Surface , 2002, Radiation research.

[5]  Sten Orrenius,et al.  Mitochondria, oxidative stress and cell death , 2007, Apoptosis.

[6]  Giuseppe Schettino,et al.  Cell type-dependent uptake, localization, and cytotoxicity of 1.9 nm gold nanoparticles , 2012, International journal of nanomedicine.

[7]  Jie Chen,et al.  Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle , 2009, Nanotechnology.

[8]  J. Robar,et al.  Generation and modelling of megavoltage photon beams for contrast-enhanced radiation therapy , 2006, Physics in medicine and biology.

[9]  E. Zubarev,et al.  Therapeutic platforms based on gold nanoparticles and their covalent conjugates with drug molecules. , 2013, Advanced drug delivery reviews.

[10]  J. Hainfeld,et al.  Gold nanoparticle imaging and radiotherapy of brain tumors in mice. , 2013, Nanomedicine.

[11]  Moshi Geso,et al.  Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[12]  A. Niroomand-rad,et al.  Radiation dose pertubation at tissue-titanium dental interfaces in head and neck cancer patients , 1996 .

[13]  D. Mukhopadhyay,et al.  Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. , 2008, Cancer research.

[14]  V. Puntes,et al.  Detoxifying Antitumoral Drugs via Nanoconjugation: The Case of Gold Nanoparticles and Cisplatin , 2012, PloS one.

[15]  Seung-Jun Seo,et al.  Therapeutic application of metallic nanoparticles combined with particle-induced x-ray emission effect , 2010, Nanotechnology.

[16]  C. Belka,et al.  Hypofractionated reirradiation for recurrent malignant glioma , 2009, Strahlentherapie und Onkologie.

[17]  T. Button,et al.  Effects of radiotherapy on mandibular reconstruction plates. , 1988, American journal of surgery.

[18]  Duncan Graham,et al.  Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin , 2010, Journal of the American Chemical Society.

[19]  Chitta Ranjan Patra,et al.  Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. , 2010, Advanced drug delivery reviews.

[20]  M. Scheulen,et al.  Oxygen radical formation and DNA damage due to enzymatic reduction of bleomycin-Fe(III) , 2004, Archives of Toxicology.

[21]  J. Petrik,et al.  Oxidative stress and cell death , 2003 .

[22]  J F Hainfeld,et al.  Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions. , 2011, The British journal of radiology.

[23]  Vincent M Rotello,et al.  The role of surface functionality on acute cytotoxicity, ROS generation and DNA damage by cationic gold nanoparticles. , 2010, Small.

[24]  Filip Braet,et al.  The selective growth inhibition of oral cancer by iron core-gold shell nanoparticles through mitochondria-mediated autophagy. , 2011, Biomaterials.

[25]  Stephen J McMahon,et al.  Radiotherapy in the presence of contrast agents: a general figure of merit and its application to gold nanoparticles , 2008, Physics in medicine and biology.

[26]  G. Bartosz,et al.  Impact of gold nanoparticle coating on redox homeostasis. , 2012, International journal of pharmaceutics.

[27]  Kihong Kim,et al.  Enhanced proton treatment in mouse tumors through proton irradiated nanoradiator effects on metallic nanoparticles , 2012, Physics in medicine and biology.

[28]  Andrew Tsourkas,et al.  Selective Targeting of Brain Tumors with Gold Nanoparticle-Induced Radiosensitization , 2013, PloS one.

[29]  P. Dulguerov,et al.  Dose variation at bone/titanium interfaces using titanium hollow screw osseointegrating reconstruction plates. , 1998, International journal of radiation oncology, biology, physics.

[30]  Jie Chen,et al.  Thio-glucose bound gold nanoparticles enhance radio-cytotoxic targeting of ovarian cancer , 2011, Nanotechnology.

[31]  E. Zubarev,et al.  Paclitaxel-functionalized gold nanoparticles. , 2007, Journal of the American Chemical Society.

[32]  M. Ghorbani,et al.  A Monte Carlo study on tissue dose enhancement in brachytherapy: a comparison between gadolinium and gold nanoparticles , 2012, Australasian Physical & Engineering Sciences in Medicine.

[33]  Srinivas Sridhar,et al.  In vitro radiosensitization by gold nanoparticles during continuous low-dose-rate gamma irradiation with I-125 brachytherapy seeds. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[34]  Sang Hyun Cho,et al.  Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: a preliminary Monte Carlo study , 2005, Physics in medicine and biology.

[35]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[36]  H. Kappus,et al.  The role of reactive oxygen species in the antitumor activity of bleomycin. , 1990, Free radical research communications.

[37]  H. Garnica-Garza Contrast-enhanced radiotherapy: feasibility and characteristics of the physical absorbed dose distribution for deep-seated tumors , 2009, Physics in medicine and biology.

[38]  Ting Guo,et al.  Nanoscale energy deposition by X-ray absorbing nanostructures. , 2007, The journal of physical chemistry. B.

[39]  Deny Hartono,et al.  Autophagy and oxidative stress associated with gold nanoparticles. , 2010, Biomaterials.

[40]  A. Popovtzer,et al.  Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study , 2011, International journal of nanomedicine.

[41]  H. García,et al.  Gold nanoparticles supported on nanoparticulate ceria as a powerful agent against intracellular oxidative stress. , 2012, Small.

[42]  Alan R Hounsell,et al.  Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies. , 2011, International journal of radiation oncology, biology, physics.

[43]  G Schettino,et al.  Evaluation of cytotoxicity and radiation enhancement using 1.9 nm gold particles: potential application for cancer therapy , 2010, Nanotechnology.

[44]  Lawrence Tamarkin,et al.  Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine , 2010, Clinical Cancer Research.

[45]  Min Soo Bae,et al.  Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy. , 2012, Biomaterials.

[46]  Jun Wang,et al.  Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells. , 2011, ACS nano.

[47]  Jie Chen,et al.  Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. , 2012, Biomaterials.

[48]  Masaki Misawa,et al.  Generation of reactive oxygen species induced by gold nanoparticles under x-ray and UV Irradiations. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[49]  L. Kèlland,et al.  The resurgence of platinum-based cancer chemotherapy , 2007, Nature Reviews Cancer.

[50]  Pablo D. Jadzinsky,et al.  Structure of a Thiol Monolayer-Protected Gold Nanoparticle at 1.1 Å Resolution , 2007, Science.

[51]  D. Casciano,et al.  Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles , 2013, International journal of nanomedicine.

[52]  Chad A Mirkin,et al.  Strategy for increasing drug solubility and efficacy through covalent attachment to polyvalent DNA-nanoparticle conjugates. , 2011, ACS nano.

[53]  Stan W. Casteel,et al.  Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity , 2010, Proceedings of the National Academy of Sciences.

[54]  I J Das,et al.  Gold microspheres: a selective technique for producing biologically effective dose enhancement. , 2000, International journal of radiation biology.

[55]  J. H. Hubbell,et al.  Tables of X-Ray Mass Attenuation Coefficients and Mass Energy-Absorption Coefficients 1 keV to 20 MeV for Elements Z = 1 to 92 and 48 Additional Substances of Dosimetric Interest , 1995 .

[56]  Erik C. Dreaden,et al.  Tamoxifen-poly(ethylene glycol)-thiol gold nanoparticle conjugates: enhanced potency and selective delivery for breast cancer treatment. , 2009, Bioconjugate chemistry.

[57]  Jie Chen,et al.  Enhanced radiation sensitivity in prostate cancer by gold-nanoparticles. , 2008, Clinical and investigative medicine. Medecine clinique et experimentale.

[58]  Michael Hsiao,et al.  Enhancement of cell radiation sensitivity by pegylated gold nanoparticles , 2010, Physics in medicine and biology.

[59]  A. Florence,et al.  Drug delivery and targeting , 1985 .

[60]  John A Kalef-Ezra,et al.  Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma , 2010, Physics in medicine and biology.

[61]  J F Hainfeld,et al.  Gold nanoparticles: a new X-ray contrast agent. , 2006, The British journal of radiology.

[62]  Subinoy Rana,et al.  Surface functionalization of nanoparticles for nanomedicine. , 2012, Chemical Society reviews.

[63]  G. Izbicki,et al.  Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathway. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[64]  A. Niroomand-rad,et al.  Radiation dose perturbation at tissue-titanium dental interfaces in head and neck cancer patients. , 1996, International journal of radiation oncology, biology, physics.

[65]  J. Hainfeld,et al.  The use of gold nanoparticles to enhance radiotherapy in mice. , 2004, Physics in medicine and biology.

[66]  Sabine Neuss,et al.  Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. , 2009, Small.

[67]  B. Tang,et al.  Effect of gold nanoparticles on glutathione depletion-induced hydrogen peroxide generation and apoptosis in HL7702 cells. , 2011, Toxicology letters.

[68]  J. Robar,et al.  Tumour dose enhancement using modified megavoltage photon beams and contrast media. , 2002, Physics in medicine and biology.